Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	glycogen phosphorylase activity	PYGB PYGL	7.57e-05	3	101	2	GO:0008184
GeneOntologyMolecularFunction	1,4-alpha-oligoglucan phosphorylase activity	PYGB PYGL	2.51e-04	5	101	2	GO:0004645
GeneOntologyMolecularFunction	ATP-dependent activity	ERCC6 HYOU1 MYO1C MYO5B RSF1 PSMC4 IDE DDX28 ATP6V0A2 RAD17 DNAH11	2.76e-04	614	101	11	GO:0140657
GeneOntologyCellularComponent	Gtr1-Gtr2 GTPase complex	RRAGB RRAGA	1.41e-04	4	102	2	GO:1990131
GeneOntologyCellularComponent	GATOR1 complex	SZT2 RRAGA	2.34e-04	5	102	2	GO:1990130
GeneOntologyCellularComponent	stereocilium membrane	MYO1C ADGRV1	3.49e-04	6	102	2	GO:0060171
GeneOntologyCellularComponent	cytosolic proteasome complex	PSMC4 IDE	4.87e-04	7	102	2	GO:0031597
GeneOntologyCellularComponent	B-WICH complex	ERCC6 MYO1C	6.48e-04	8	102	2	GO:0110016
GeneOntologyCellularComponent	ciliary transition zone	SPATA7 INTU PCDHB15 ADGRV1	6.66e-04	81	102	4	GO:0035869
Domain	GREB1	GREB1L GREB1	2.90e-05	2	101	2	PF15782
Domain	GREB1	GREB1L GREB1	2.90e-05	2	101	2	IPR028422
Domain	Cadherin_C	PCDHGA7 PCDHGA2 PCDHB15 PCDHB16	7.70e-05	42	101	4	IPR032455
Domain	Cadherin_C_2	PCDHGA7 PCDHGA2 PCDHB15 PCDHB16	7.70e-05	42	101	4	PF16492
Domain	PHOSPHORYLASE	PYGB PYGL	8.66e-05	3	101	2	PS00102
Domain	Phosphorylase	PYGB PYGL	8.66e-05	3	101	2	PF00343
Domain	Glycg_phsphrylas	PYGB PYGL	8.66e-05	3	101	2	IPR011833
Domain	Glyco_trans_35	PYGB PYGL	8.66e-05	3	101	2	IPR000811
Domain	Gtr1_RagA	RRAGB RRAGA	1.73e-04	4	101	2	PF04670
Domain	Gtr1_RagA	RRAGB RRAGA	1.73e-04	4	101	2	IPR006762
Domain	Cadherin_2	PCDHGA7 PCDHGA2 PCDHB15 PCDHB16	4.23e-04	65	101	4	PF08266
Domain	Cadherin_N	PCDHGA7 PCDHGA2 PCDHB15 PCDHB16	4.23e-04	65	101	4	IPR013164
Domain	DUF3398	DOCK10 DOCK7	4.28e-04	6	101	2	PF11878
Domain	DOCK_C/D_N	DOCK10 DOCK7	4.28e-04	6	101	2	IPR021816
Domain	Cadherin	PCDHGA7 PCDHGA2 PCDHB15 FREM3 PCDHB16	4.52e-04	118	101	5	IPR002126
Domain	Calx_beta	ADGRV1 FREM3	7.94e-04	8	101	2	SM00237
Domain	Calx_beta	ADGRV1 FREM3	1.02e-03	9	101	2	IPR003644
Domain	Calx-beta	ADGRV1 FREM3	1.02e-03	9	101	2	PF03160
Domain	DOCK_C	DOCK10 DOCK7	1.54e-03	11	101	2	IPR010703
Domain	DHR-1_domain	DOCK10 DOCK7	1.54e-03	11	101	2	IPR027007
Domain	DHR_2	DOCK10 DOCK7	1.54e-03	11	101	2	PS51651
Domain	DHR_1	DOCK10 DOCK7	1.54e-03	11	101	2	PS51650
Domain	DOCK-C2	DOCK10 DOCK7	1.54e-03	11	101	2	PF14429
Domain	DHR-2	DOCK10 DOCK7	1.54e-03	11	101	2	IPR027357
Domain	DHR-2	DOCK10 DOCK7	1.54e-03	11	101	2	PF06920
Domain	DOCK	DOCK10 DOCK7	1.54e-03	11	101	2	IPR026791
Domain	TPR-like_helical_dom	TANC2 RGPD1 NAPB TTC12 NUB1 CRTAP	1.67e-03	233	101	6	IPR011990
Domain	ARM-type_fold	RALGAPA1 PDCD4 TTC12 EFR3B UNC79 NIPBL AGTPBP1	2.44e-03	339	101	7	IPR016024
Domain	Cadherin_CS	PCDHGA7 PCDHGA2 PCDHB15 PCDHB16	2.90e-03	109	101	4	IPR020894
Domain	CADHERIN_1	PCDHGA7 PCDHGA2 PCDHB15 PCDHB16	3.31e-03	113	101	4	PS00232
Domain	Cadherin	PCDHGA7 PCDHGA2 PCDHB15 PCDHB16	3.31e-03	113	101	4	PF00028
Domain	CADHERIN_2	PCDHGA7 PCDHGA2 PCDHB15 PCDHB16	3.41e-03	114	101	4	PS50268
Domain	-	PCDHGA7 PCDHGA2 PCDHB15 PCDHB16	3.41e-03	114	101	4	2.60.40.60
Domain	CA	PCDHGA7 PCDHGA2 PCDHB15 PCDHB16	3.52e-03	115	101	4	SM00112
Domain	Cadherin-like	PCDHGA7 PCDHGA2 PCDHB15 PCDHB16	3.63e-03	116	101	4	IPR015919
Domain	C1_1	DGKZ VAV3 ARHGEF2	3.63e-03	57	101	3	PF00130
Domain	ZF_DAG_PE_1	DGKZ VAV3 ARHGEF2	5.04e-03	64	101	3	PS00479
Domain	ZF_DAG_PE_2	DGKZ VAV3 ARHGEF2	5.04e-03	64	101	3	PS50081
Domain	C1	DGKZ VAV3 ARHGEF2	5.26e-03	65	101	3	SM00109
Domain	-	TANC2 RGPD1 NAPB TTC12 CRTAP	5.34e-03	207	101	5	1.25.40.10
Pubmed	Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation.	MYO1C PDGFRB RBM33 U2AF2 DIDO1 CNTN6 GREB1L PIEZO2 METTL21A ZNF451 ANKRD24 NUB1 ARHGEF2 MYL12B NIPBL NUP160 AGTPBP1 OPLAH	1.50e-08	1215	102	18	15146197
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	TANC2 RALGAPA1 HYOU1 MYO1C MYO5B DGKZ ERBIN NDUFS1 SRRT PACS1 DLGAP3 NAPB CLMN DOCK7 PYGB ARHGEF2 MYL12B AGTPBP1 DNAH11	3.24e-08	1431	102	19	37142655
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	RALGAPA1 HYOU1 RBM33 PSMC4 BIRC6 ERBIN NDUFS1 EDEM3 CLMN ZNF451 NUB1 ARHGEF2 PATJ AGTPBP1	3.25e-08	733	102	14	34672954
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	RALGAPA1 HYOU1 MYO1C MYO5B PSMC4 ITPRID2 IDE BIRC6 ERBIN PPM1B FAN1 PACS1 EFR3B ARHGEF2 HERC1 AGTPBP1	7.00e-08	1049	102	16	27880917
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	RALGAPA1 INTU STXBP5L LMBR1 U2AF2 IDE ADGRV1 ERBIN PCDHB16 STK10 PACS1 CFAP20DC CLMN TTC12 ANKRD24 GREB1 PATJ VPS13B	3.13e-07	1489	102	18	28611215
Pubmed	EDEM1 Drives Misfolded Protein Degradation via ERAD and Exploits ER-Phagy as Back-Up Mechanism When ERAD Is Impaired.	HYOU1 EPG5 UBE4A EDEM3 RRAGA ATG9A HERC1	3.16e-07	150	102	7	32423001
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	HYOU1 MYO1C RSF1 U2AF2 DIDO1 BIRC6 NDUFS1 DOCK7 PYGB PYGL NIPBL NUP160	5.04e-07	653	102	12	22586326
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	HYOU1 MYO1C RBM33 PSMC4 U2AF2 ITPRID2 IDE BIRC6 NDUFS1 UBE4A CLMN PLD6 ARHGEF2 HERC1 NUP160 VPS13B DDX28	1.62e-06	1496	102	17	32877691
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	FILIP1 MYO1C DIDO1 ITPRID2 PNISR ERBIN STK10 SRRT PACS1 ARHGEF2 NIPBL AGTPBP1	2.94e-06	774	102	12	15302935
Pubmed	TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions.	PSMC4 ITPRID2 PNISR NDUFS1 STK10 SRRT PAXIP1 DOCK7 ATG9A PATJ NUP160 DDX28 CRTAP	3.12e-06	922	102	13	27609421
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	INTU DOCK10 ERBIN PCDHB16 EPG5 ZNF451 DOCK7 VPS13B AGTPBP1	3.31e-06	407	102	9	12693553
Pubmed	Proteomic Analysis of the EWS-Fli-1 Interactome Reveals the Role of the Lysosome in EWS-Fli-1 Turnover.	HYOU1 RBM33 GLRX3 RSF1 U2AF2 PNISR SRRT COPS7B NIPBL	4.69e-06	425	102	9	24999758
Pubmed	Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.	RSF1 PSMC4 NDUFS1 STK10 METTL21A CLMN ZNF451 PYGL CHPF RAD17 DNAH11	5.93e-06	689	102	11	36543142
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	TANC2 SPATA7 INTU MYO5B GLRX3 PSMC4 NDUFS1 PACS1 PDRG1 DOCK7 COPS7B PYGL CHPF MYL12B NUP160	7.18e-06	1321	102	15	27173435
Pubmed	Defining the human deubiquitinating enzyme interaction landscape.	MYO1C PSMC4 TYSND1 NDUFS1 PDCD4 DOCK7 COPS7B PYGL ARHGEF2 MYL12B NUP160 CRTAP RAD17	7.89e-06	1005	102	13	19615732
Pubmed	Cerebellar mutations affecting the postnatal survival of Purkinje cells in the mouse disclose a longitudinal pattern of differentially sensitive cells.	HERC1 AGTPBP1	8.52e-06	2	102	2	3678603
Pubmed	CircRBM33 induces endothelial dysfunction by targeting the miR-6838-5p/PDCD4 axis affecting blood-brain barrier in mice with cerebral ischemia-reperfusion injury.	RBM33 PDCD4	8.52e-06	2	102	2	37927249
Pubmed	Exome-wide Association Study Identifies GREB1L Mutations in Congenital Kidney Malformations.	GREB1L GREB1	8.52e-06	2	102	2	29100090
Pubmed	RagA is a functional homologue of S. cerevisiae Gtr1p involved in the Ran/Gsp1-GTPase pathway.	RRAGB RRAGA	8.52e-06	2	102	2	9394008
Pubmed	Cloning of a novel family of mammalian GTP-binding proteins (RagA, RagBs, RagB1) with remote similarity to the Ras-related GTPases.	RRAGB RRAGA	8.52e-06	2	102	2	7499430
Pubmed	A Gene Implicated in Activation of Retinoic Acid Receptor Targets Is a Novel Renal Agenesis Gene in Humans.	GREB1L GREB1	8.52e-06	2	102	2	28739660
Pubmed	A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins.	TANC2 DPY19L3 GRK6 BIRC6 NDUFS1 STK10 EFR3B ATG9A HERC1 NUP160 DDX28	8.85e-06	719	102	11	35337019
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	ERCC6 MYO1C RSF1 DOCK10 PSMC4 U2AF2 BIRC6 ERBIN NDUFS1 SRRT PYGB PYGL ARHGEF2 NIPBL NUP160	9.54e-06	1353	102	15	29467282
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	TANC2 RBM33 DGKZ TYSND1 PNISR ERBIN PDCD4 PPM1B STK10 SRRT PAXIP1 DOCK7 AGTPBP1	1.11e-05	1038	102	13	26673895
Pubmed	An Interaction Landscape of Ubiquitin Signaling.	PSMC4 PPM1B ZNF451 PLD6 NUB1 ARHGEF2 HERC1 MYL12B AGTPBP1	1.26e-05	481	102	9	28190767
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	LARGE2 HYOU1 DIDO1 DGKZ ERBIN PACS1 CLMN DCAF17 HERC1 PATJ VPS13B ATP6V0A2 RAD17	1.75e-05	1084	102	13	11544199
Pubmed	Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism.	RALGAPA1 MYO1C RSF1 LMBR1 PSMC4 DIDO1 NDUFS1 EPG5 FAN1 GREB1L NAPB ATG9A	1.76e-05	925	102	12	28986522
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	ERCC6 HYOU1 MYO1C MYO5B U2AF2 DIDO1 ITPRID2 PDCD4 SRRT DOCK7 ARHGEF2 PATJ MYL12B NUP160	1.85e-05	1257	102	14	36526897
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	TANC2 RSF1 RGPD1 IDE PRDM5 NDUFS1 PAXIP1 ARHGEF2 NIPBL DNAH11	1.89e-05	638	102	10	31182584
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	INTU HYOU1 MYO1C MYO5B PCDHGA7 PCDHGA2 GRK6 RSF1 RGPD1 U2AF2 PNISR ERBIN NDUFS1 ARHGEF2 NIPBL	2.01e-05	1442	102	15	35575683
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	HYOU1 C12orf56 DOCK10 DIDO1 SRRT PACS1 DOCK7 PYGB ARHGEF2 PATJ	2.21e-05	650	102	10	38777146
Pubmed	ZZW-115-dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agents.	MYO1C PSMC4 U2AF2 ITPRID2 ERBIN PPM1B SRRT DOCK7 NUP160 CRTAP	2.52e-05	660	102	10	32780723
Pubmed	Metabolism. Differential regulation of mTORC1 by leucine and glutamine.	RRAGB RRAGA	2.55e-05	3	102	2	25567907
Pubmed	Ars2 is overexpressed in human cholangiocarcinomas and its depletion increases PTEN and PDCD4 by decreasing microRNA-21.	PDCD4 SRRT	2.55e-05	3	102	2	22213145
Pubmed	Target neuron controls the integrity of afferent axon phenotype: a study on the Purkinje cell-climbing fiber system in cerebellar mutant mice.	HERC1 AGTPBP1	2.55e-05	3	102	2	7891151
Pubmed	RagA, but not RagB, is essential for embryonic development and adult mice.	RRAGB RRAGA	2.55e-05	3	102	2	24768164
Pubmed	Nutrient mTORC1 signaling underpins regulatory T cell control of immune tolerance.	RRAGB RRAGA	2.55e-05	3	102	2	31649036
Pubmed	Rag GTPases are cardioprotective by regulating lysosomal function.	RRAGB RRAGA	2.55e-05	3	102	2	24980141
Pubmed	Host E3 ligase HUWE1 attenuates the proapoptotic activity of the MERS-CoV accessory protein ORF3 by promoting its ubiquitin-dependent degradation.	HYOU1 GLRX3 PSMC4 BIRC6 NDUFS1 SRRT DOCK7 PYGB NUP160	2.87e-05	534	102	9	35032548
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	ERCC6 RBM33 DIDO1 DGKZ ITPRID2 PNISR ERBIN NDUFS1 GREB1L SRRT ARHGEF2 PATJ NIPBL DDX28 ATP6V0A2	3.10e-05	1497	102	15	31527615
Pubmed	Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation.	MYO1C SZT2 DOCK10 PSMC4 DOCK7 PYGL	3.56e-05	208	102	6	33230847
Pubmed	Comparative DNA sequence analysis of mouse and human protocadherin gene clusters.	PCDHGA7 PCDHGA2 PCDHB15 PCDHB16	4.92e-05	68	102	4	11230163
Pubmed	The Groucho-associated phosphatase PPM1B displaces Pax transactivation domain interacting protein (PTIP) to switch the transcription factor Pax2 from a transcriptional activator to a repressor.	PPM1B PAXIP1	5.09e-05	4	102	2	25631048
Pubmed	YAP plays a crucial role in the development of cardiomyopathy in lysosomal storage diseases.	RRAGB RRAGA	5.09e-05	4	102	2	33373332
Pubmed	Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.	ERCC6 RBM33 ZNF451 PAXIP1 ARHGEF2 NIPBL	5.11e-05	222	102	6	37071664
Pubmed	Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.	PSMC4 U2AF2 DIDO1 PDCD4 SRRT NIPBL NUP160	5.76e-05	332	102	7	32786267
Pubmed	Local anesthetics impair the growth and self-renewal of glioblastoma stem cells by inhibiting ZDHHC15-mediated GP130 palmitoylation.	STXBP5L RSF1 PPM1B EPG5	5.83e-05	71	102	4	33541421
Pubmed	A striking organization of a large family of human neural cadherin-like cell adhesion genes.	PCDHGA7 PCDHGA2 PCDHB15 PCDHB16	6.15e-05	72	102	4	10380929
Pubmed	Functional proteomics mapping of a human signaling pathway.	ERCC6 GLRX3 U2AF2 ERBIN EPG5 ZNF451 PAXIP1 HERC1 CHPF	6.27e-05	591	102	9	15231748
Pubmed	Cadherin superfamily genes: functions, genomic organization, and neurologic diversity.	PCDHGA7 PCDHGA2 PCDHB15 PCDHB16	6.85e-05	74	102	4	10817752
Pubmed	Characterization of cDNA clones selected by the GeneMark analysis from size-fractionated cDNA libraries from human brain.	TANC2 MYO5B PACS1 CLMN	7.61e-05	76	102	4	10574461
Pubmed	Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members.	PCDHGA7 PCDHGA2 PCDHB15 PCDHB16	8.01e-05	77	102	4	10835267
Pubmed	The Shh Topological Domain Facilitates the Action of Remote Enhancers by Reducing the Effects of Genomic Distances.	RBM33 LMBR1	8.47e-05	5	102	2	27867070
Pubmed	SH3BP4 is a negative regulator of amino acid-Rag GTPase-mTORC1 signaling.	RRAGB RRAGA	8.47e-05	5	102	2	22575674
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	HYOU1 GLRX3 PSMC4 RRAGB IDE BIRC6 PDCD4 SRRT COPS7B PYGB PYGL HERC1 NUP160 CRTAP	8.99e-05	1455	102	14	22863883
Pubmed	Network organization of the huntingtin proteomic interactome in mammalian brain.	MYO5B PSMC4 U2AF2 NDUFS1 NAPB PYGB PYGL ARHGEF2 ATP6V0A2	9.13e-05	621	102	9	22794259
Pubmed	Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes.	PCDHGA7 PCDHGA2 PCDHB15 PCDHB16	9.29e-05	80	102	4	10716726
Pubmed	Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation.	TANC2 MYO1C ITPRID2 ERBIN SRRT PDRG1 DDX28	9.72e-05	361	102	7	30344098
Pubmed	Large-scale mapping of human protein-protein interactions by mass spectrometry.	HYOU1 MYO1C GLRX3 PSMC4 U2AF2 PDCD4 PPM1B SRRT UBE4A ARHGEF2 HERC1 UNC79 NUP160	9.89e-05	1284	102	13	17353931
Pubmed	Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets.	ERCC6 RSF1 HERC1 NIPBL RAD17	1.03e-04	157	102	5	30686591
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	ERCC6 RSF1 DIDO1 PDCD4 STK10 SRRT ARHGEF2 NIPBL	1.21e-04	503	102	8	16964243
Pubmed	A bead-based approach for large-scale identification of in vitro kinase substrates.	RBM33 RSF1 BIRC6 PDCD4 SRRT	1.23e-04	163	102	5	22113938
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	TANC2 RGPD1 DIDO1 DGKZ ERBIN DLGAP3 DOCK7 ARHGEF2 UNC79 NIPBL FERMT3	1.25e-04	963	102	11	28671696
Pubmed	A novel human nucleolar protein, Nop132, binds to the G proteins, RRAG A/C/D.	RRAGB RRAGA	1.27e-04	6	102	2	14660641
Pubmed	Vav family proteins couple to diverse cell surface receptors.	PDGFRB VAV3	1.27e-04	6	102	2	10938113
Pubmed	Piezo2 expression and its alteration by mechanical forces in mouse mesangial cells and renin-producing cells.	PDGFRB PIEZO2	1.27e-04	6	102	2	35273307
Pubmed	Novel G proteins, Rag C and Rag D, interact with GTP-binding proteins, Rag A and Rag B.	RRAGB RRAGA	1.27e-04	6	102	2	11073942
Pubmed	Regulation of TORC1 in response to amino acid starvation via lysosomal recruitment of TSC2.	RRAGB RRAGA	1.27e-04	6	102	2	24529380
Pubmed	Mutations in GREB1L Cause Bilateral Kidney Agenesis in Humans and Mice.	GREB1L GREB1	1.27e-04	6	102	2	29100091
Pubmed	Recruitment of folliculin to lysosomes supports the amino acid-dependent activation of Rag GTPases.	RRAGB RRAGA	1.27e-04	6	102	2	24081491
Pubmed	The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1.	RRAGB RRAGA	1.27e-04	6	102	2	18497260
Pubmed	Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma.	DOCK10 ERBIN STK10 PACS1 DOCK7 EFR3B FERMT3	1.27e-04	377	102	7	38117590
Pubmed	Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer.	MYO1C MYO5B PSMC4 ITPRID2 TYSND1 MYL12B	1.32e-04	264	102	6	32814769
Pubmed	Sestrins function as guanine nucleotide dissociation inhibitors for Rag GTPases to control mTORC1 signaling.	RRAGB RRAGA	1.77e-04	7	102	2	25259925
Pubmed	Mapping the Shh long-range regulatory domain.	RBM33 LMBR1	1.77e-04	7	102	2	25252942
Pubmed	Estrogen-regulated feedback loop limits the efficacy of estrogen receptor-targeted breast cancer therapy.	STXBP5L IDE ERBIN CNTN6 AXDND1 ZNF451 DCAF17 EFR3B VPS13B	1.92e-04	686	102	9	29987050
Pubmed	Virus-Host Interactome and Proteomic Survey Reveal Potential Virulence Factors Influencing SARS-CoV-2 Pathogenesis.	HYOU1 PSMC4 NDUFS1 EDEM3 ATG9A HERC1	2.00e-04	285	102	6	32838362
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	TANC2 RALGAPA1 ITPRID2 ERBIN SRRT CLMN DOCK7 NUB1 ARHGEF2 PATJ	2.25e-04	861	102	10	36931259
Pubmed	Ragulator is a GEF for the rag GTPases that signal amino acid levels to mTORC1.	RRAGB RRAGA	2.36e-04	8	102	2	22980980
Pubmed	Distinct strategies to make nucleosomal DNA accessible.	ERCC6 MYO1C	2.36e-04	8	102	2	12769854
Pubmed	Nuclear myosin 1 contributes to a chromatin landscape compatible with RNA polymerase II transcription activation.	ERCC6 MYO1C	2.36e-04	8	102	2	26044184
Pubmed	Amino acid-dependent NPRL2 interaction with Raptor determines mTOR Complex 1 activation.	RRAGB RRAGA	2.36e-04	8	102	2	26582740
Pubmed	A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome.	PDGFRB DOCK10 LMBR1 U2AF2 PPM1B HERC1 AGTPBP1	2.46e-04	420	102	7	28065597
Pubmed	Prediction of the coding sequences of unidentified human genes. XV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	FILIP1 INTU BIRC6 ERBIN	2.47e-04	103	102	4	10574462
Pubmed	Identification of multi-SH3 domain-containing protein interactome in pancreatic cancer: a yeast two-hybrid approach.	BIRC6 PPM1B SRRT VAV3	2.75e-04	106	102	4	18654987
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	RALGAPA1 ERBIN STK10 PACS1 PIEZO2 DOCK7 PATJ VPS13B	2.79e-04	569	102	8	30639242
Pubmed	Ex vivo Quantitative Proteomic Analysis of Serotonin Transporter Interactome: Network Impact of the SERT Ala56 Coding Variant.	RALGAPA1 MYO1C DGKZ ADGRV1 ERBIN DLGAP3 MYL12B	2.83e-04	430	102	7	32581705
Pubmed	Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics.	CNNM2 HYOU1 MYO1C PSMC4 ERBIN PDRG1 PYGL HERC1	2.92e-04	573	102	8	28330616
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	MYO1C MYO5B PSMC4 U2AF2 ERBIN NDUFS1 PDCD4 PPM1B SRRT ARHGEF2 PATJ MYL12B	2.96e-04	1247	102	12	27684187
Pubmed	DNA cross-link repair safeguards genomic stability during premeiotic germ cell development.	ERCC6 FAN1	3.03e-04	9	102	2	31367016
Pubmed	The WSTF-SNF2h chromatin remodeling complex interacts with several nuclear proteins in transcription.	ERCC6 MYO1C	3.03e-04	9	102	2	16603771
Pubmed	Nuclear myosin 1c facilitates the chromatin modifications required to activate rRNA gene transcription and cell cycle progression.	ERCC6 MYO1C	3.03e-04	9	102	2	23555303
Pubmed	Amino acids activate mammalian target of rapamycin (mTOR) complex 1 without changing Rag GTPase guanyl nucleotide charging.	RRAGB RRAGA	3.03e-04	9	102	2	24337580
Pubmed	p62 is a key regulator of nutrient sensing in the mTORC1 pathway.	RRAGB RRAGA	3.03e-04	9	102	2	21981924
Pubmed	A new role for the architecture of microvillar actin bundles in apical retention of membrane proteins.	MYO1C MYO5B MYL12B	3.18e-04	45	102	3	22114352
Pubmed	Investigation of genetic susceptibility factors for human longevity - a targeted nonsynonymous SNP study.	GLRX3 DIDO1 BIRC6 PDCD4 PYGB PYGL	3.31e-04	313	102	6	20800603
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	TANC2 RALGAPA1 BIRC6 DOCK7 ARHGEF2 PATJ NUP160	3.53e-04	446	102	7	24255178
Pubmed	Leucyl-tRNA synthetase is an intracellular leucine sensor for the mTORC1-signaling pathway.	RRAGB RRAGA	3.77e-04	10	102	2	22424946
Pubmed	Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.	RALGAPA1 CNNM2 HYOU1 MYO5B PSMC4 IDE TYSND1 EDEM3 CHPF	3.84e-04	754	102	9	33060197
Pubmed	Interaction proteomics analysis of polycomb proteins defines distinct PRC1 complexes in mammalian cells.	ERCC6 DGKZ UBE4A RAD17	3.88e-04	116	102	4	21282530
Interaction	EDEM1 interactions	HYOU1 PNISR EPG5 UBE4A EDEM3 RRAGA ATG9A HERC1 ATP6V0A2	8.05e-07	202	101	9	int:EDEM1
Cytoband	7q36	LMBR1 PAXIP1 NUB1	3.00e-05	27	102	3	7q36
Cytoband	5q31	PCDHGA7 PCDHGA2 PCDHB15 PCDHB16	1.31e-04	115	102	4	5q31
Cytoband	Ensembl 112 genes in cytogenetic band chr7q36	RBM33 LMBR1 PAXIP1 NUB1	4.52e-04	159	102	4	chr7q36
Cytoband	11p11.2	LARGE2 DGKZ NUP160	8.60e-04	83	102	3	11p11.2
Cytoband	5q13	ADGRV1 RAD17	1.10e-03	22	102	2	5q13
Cytoband	10q24	PSD PDCD4	2.77e-03	35	102	2	10q24
GeneFamily	Glycogen phosphorylases	PYGB PYGL	3.03e-05	3	58	2	437
GeneFamily	Clustered protocadherins	PCDHGA7 PCDHGA2 PCDHB15 PCDHB16	5.25e-05	64	58	4	20
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	PSD DOCK10 VAV3 ARHGEF2 FERMT3	5.13e-04	206	58	5	682
Coexpression	BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING	SPATA7 GRK6 U2AF2 PNISR SRRT EDEM3 ARHGEF2 HERC1 FUT4 PATJ CRTAP RAD17	6.59e-07	506	102	12	M253
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	RALGAPA1 RBM33 GRK6 RSF1 DOCK10 PNISR BIRC6 ERBIN PDCD4 PPM1B EPG5 STK10 PACS1 VAV3 HERC1 MYL12B NIPBL VPS13B FERMT3	4.33e-06	1492	102	19	M40023
CoexpressionAtlas	DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_top-relative-expression-ranked_1000	RALGAPA1 LARGE2 MYO5B DIDO1 IDE BIRC6 UBE4A NAPB CLMN TTC12 DCAF17 VAV3 PATJ VPS13B	2.35e-05	786	102	14	gudmap_developingKidney_e15.5_Medullary collecting duct_1000
CoexpressionAtlas	DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#4_top-relative-expression-ranked_1000	RALGAPA1 IDE BIRC6 UBE4A NAPB DCAF17 VAV3 VPS13B	3.79e-05	261	102	8	gudmap_developingKidney_e15.5_Medullary collecting duct_1000_k4
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FILIP1 MYO5B FREM3 PRDM5 CNTN6 ARHGEF2 PATJ	1.49e-07	173	102	7	b799c06a6a5754668e789f70c0c8bc1508568575
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	RALGAPA1 RSF1 LMBR1 ADGRV1 BIRC6 NDUFS1 VPS13B	3.14e-07	193	102	7	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	IDE BIRC6 ERBIN UBE4A DCAF17 VPS13B	4.46e-06	186	102	6	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	RALGAPA1 DOCK10 BIRC6 EPG5 HERC1 NIPBL	4.74e-06	188	102	6	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	control-immature_Neutrophil\|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TANC2 HYOU1 EDEM3 AXDND1 PYGL AGTPBP1	6.02e-06	196	102	6	e34fd3e7a5b1c22a81fd3208e6d58bdb846d51c4
ToppCell	(7)_Epithelial-I_(AT1)\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	MYO1C MYO5B FREM3 CNTN6 EFR3B PATJ	6.02e-06	196	102	6	150554fa06868d29b0608189862eef6505ba757f
ToppCell	medial-Hematologic-B_cell-2\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	LARGE2 TNFRSF17 AXDND1 DLGAP3 PLD6 UNC79	6.20e-06	197	102	6	095134c36f8d2a24c9085017b8d81f04a36cdd1d
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	TANC2 LARGE2 FILIP1 HYOU1 PATJ CHPF	6.20e-06	197	102	6	1485933986921ff45669d9b7501c8d17050b3e97
ToppCell	medial-2-Hematologic-B_cell\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	LARGE2 TNFRSF17 AXDND1 DLGAP3 PLD6 UNC79	6.20e-06	197	102	6	4b8c8b9b9a85ebe6862306c9e13089a24fc4e98a
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	LARGE2 FILIP1 MYO5B ADGRV1 CNTN6 PATJ	6.20e-06	197	102	6	3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3
ToppCell	medial-Hematologic-B_cell\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	LARGE2 TNFRSF17 AXDND1 DLGAP3 PLD6 UNC79	6.20e-06	197	102	6	124c5107045069613493e3c61763eeca0a2119b6
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	TANC2 FILIP1 MYO5B ADGRV1 PATJ CHPF	6.38e-06	198	102	6	285f729140b1df029c24f6ca1d2438470ac51794
ToppCell	Macroglial-Astrocytes\|Macroglial / cells hierarchy compared to all cells using T-Statistic	INTU PDGFRB ADGRV1 DOCK7 EFR3B VAV3	6.76e-06	200	102	6	941536b7c32f1e63c70535233b2ccce0cd7bf96e
ToppCell	Macroglial-Astrocytes-SLC14A1---\|Macroglial / cells hierarchy compared to all cells using T-Statistic	INTU PDGFRB ADGRV1 DOCK7 EFR3B VAV3	6.76e-06	200	102	6	d6fcbf4f4bc1b89a9929d7b114c6b907b6979900
ToppCell	Macroglial-Astrocytes-SLC14A1----L1-6\|Macroglial / cells hierarchy compared to all cells using T-Statistic	INTU PDGFRB ADGRV1 DOCK7 EFR3B VAV3	6.76e-06	200	102	6	f861509b54185d89931db64da1b9d81986cc7938
ToppCell	Macroglial-Astrocytes-SLC14A1\|Macroglial / cells hierarchy compared to all cells using T-Statistic	INTU PDGFRB ADGRV1 DOCK7 EFR3B VAV3	6.76e-06	200	102	6	16f468217427921fa18c6d078ffa990eb019b257
ToppCell	Macroglial-Astrocytes-SLC14A1--\|Macroglial / cells hierarchy compared to all cells using T-Statistic	INTU PDGFRB ADGRV1 DOCK7 EFR3B VAV3	6.76e-06	200	102	6	0442894c39eec69850c090957a5dc7bcecd21e04
ToppCell	Macroglial-Astrocytes-SLC14A1-\|Macroglial / cells hierarchy compared to all cells using T-Statistic	INTU PDGFRB ADGRV1 DOCK7 EFR3B VAV3	6.76e-06	200	102	6	01819446deeab9054f5cfe889d53bb49d137dbc0
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_atypical\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRB PCDHB15 PGF PCDHB16 PIEZO2	2.32e-05	148	102	5	b7b5521162effc1024e7c399f690cd86d0b2f750
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRB DOCK10 PGF PIEZO2 GREB1	4.13e-05	167	102	5	b4ef07117d14da3d5fbced949e4dfcb01c392295
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRB DOCK10 PGF PIEZO2 GREB1	4.13e-05	167	102	5	94fc7df7ca55cd722a8dbd153201a29891217473
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRB DOCK10 PGF PIEZO2 GREB1	4.13e-05	167	102	5	eff3723fe60755272eca237459165e436e919ece
ToppCell	E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DOCK10 FAN1 STK10 PYGL FERMT3	4.37e-05	169	102	5	305cedbd97059029d7d2a248a8a4b6cfe281aa54
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRB DOCK10 PGF PIEZO2 PYGL	4.76e-05	172	102	5	08a3fe536b1b064c5ee7779bc2b1115a5963a26b
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRB DOCK10 PGF PIEZO2 PYGL	4.76e-05	172	102	5	553701349444eb366df3c11f54bb093434f153c6
ToppCell	P15-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	DPY19L3 ERCC6 STK10 NAPB PYGL	5.30e-05	176	102	5	792f414f5092aba14260b8e16378e793a822498e
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FILIP1 MYO5B CNTN6 EFR3B PATJ	5.75e-05	179	102	5	4f6ca313b78aa93557937a046c44dcf8bcc9963c
ToppCell	E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_prolif\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TANC2 MYO5B IDE CFAP20DC ATP6V0A2	6.06e-05	181	102	5	f6629fa71bb94405f523f63a9264cacf6d15c5f4
ToppCell	COVID-19-lung-AT1\|lung / Disease (COVID-19 only), tissue and cell type	MYO5B ADGRV1 CNTN6 EFR3B PATJ	6.38e-05	183	102	5	942530449e9c6583705eeb8f6f12621daea57252
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STXBP5L ADGRV1 PIEZO2 UNC79 DNAH11	6.55e-05	184	102	5	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RSF1 DOCK10 BIRC6 ERBIN NIPBL	6.55e-05	184	102	5	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STXBP5L ADGRV1 PIEZO2 UNC79 DNAH11	6.55e-05	184	102	5	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STXBP5L ADGRV1 PIEZO2 UNC79 DNAH11	6.55e-05	184	102	5	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	LARGE2 MYO5B ADGRV1 VAV3 PATJ	6.55e-05	184	102	5	fa4915b0498f3069fd5ef497286445528f75187e
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FILIP1 MYO5B CNTN6 EFR3B PATJ	6.72e-05	185	102	5	1c222f7285d6e3dae0354dc7e853ddc0ea55e63e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FILIP1 PDGFRB PGF PIEZO2 CLMN	6.72e-05	185	102	5	51dfe6ac7df8b330343b37e3bee71e5c65267189
ToppCell	droplet-Marrow-nan-3m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RSF1 DOCK10 ERBIN VAV3 NIPBL	6.72e-05	185	102	5	7adfa929930cfa795cbfbd9f1a0b439e08aa765d
ToppCell	droplet-Lung-LUNG-1m-Myeloid\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DOCK10 STK10 CLMN PYGL PATJ	6.72e-05	185	102	5	53a5218c1e6eb12daccde3d6e02f337e2586d74c
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FILIP1 PDGFRB PGF PIEZO2 CLMN	6.72e-05	185	102	5	a8c02cec3c414f3a0da9f2d6d28ce563b0030705
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	FILIP1 ADGRV1 FREM3 CNTN6 PATJ	7.07e-05	187	102	5	4ae7465174e0295d2c3b614b321a3b2f514dd22a
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FILIP1 PDGFRB PGF CLMN DNAH11	7.07e-05	187	102	5	ec4b694487cc446999c7b27b119950a4f252c4b3
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FILIP1 PDGFRB PGF CLMN DNAH11	7.07e-05	187	102	5	530e4e6d91b5c0d9aa4543caa2b734a1674c5788
ToppCell	PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	LARGE2 MYO5B ADGRV1 VAV3 PATJ	7.62e-05	190	102	5	625c08a0e5227efc46daa512fd579c3938ff76c7
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	MYO5B ADGRV1 CNTN6 GREB1L PATJ	7.81e-05	191	102	5	60ff989fe99d243a3d52955223680cdd1f1917a4
ToppCell	CD8+_Memory_T_cell-CV-7\|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster	HYOU1 DOCK10 BIRC6 UBE4A AGTPBP1	7.81e-05	191	102	5	9454f642c3621370fa23640b631301346b300950
ToppCell	Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|World / Lineage, Cell type, age group and donor	FILIP1 MYO5B ADGRV1 ARHGEF2 PATJ	7.81e-05	191	102	5	d3733c8c4bda70c4390e5601fdda6188a64be944
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-Z\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	FILIP1 MYO1C PDGFRB TYSND1 PGF	8.00e-05	192	102	5	0b954a4e5857dac45d97c491af9b27cb2d1bd339
ToppCell	NS-moderate-d_0-4\|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	FILIP1 INTU ADGRV1 CLMN DNAH11	8.20e-05	193	102	5	ea345d34440b25f65358a53dc72831998d1c3620
ToppCell	356C-Epithelial_cells-Epithelial-I_(AT1)\|356C / Donor, Lineage, Cell class and subclass (all cells)	MYO1C MYO5B FREM3 CNTN6 EFR3B	8.61e-05	195	102	5	07a3ef6b0f1201fe2bcb9ea426b8f7a69beb4904
ToppCell	356C-Epithelial_cells-Epithelial-I_(AT1)-\|356C / Donor, Lineage, Cell class and subclass (all cells)	MYO1C MYO5B FREM3 CNTN6 EFR3B	8.61e-05	195	102	5	b65511770ed67f7447847e2187555b362988af45
ToppCell	COVID-19-kidney-TAL\|kidney / Disease (COVID-19 only), tissue and cell type	TANC2 ITPRID2 ADGRV1 CLMN PYGB	8.82e-05	196	102	5	04f5eb206ed3016a737609a3ebac0c1fcabb94ef
ToppCell	Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2\|Control_saline / Treatment groups by lineage, cell group, cell type	LARGE2 FILIP1 ADGRV1 PNISR PATJ	9.03e-05	197	102	5	44a59dfb889577b3160a5b13ada1276771a00241
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT1\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYO1C MYO5B CNTN6 EFR3B AGTPBP1	9.03e-05	197	102	5	8d5097898dd01cedb04cb694cb480c931e08462c
ToppCell	ILEUM-non-inflamed-(8)_Fibroblast-(8)_Pericytes\|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	FILIP1 CNNM2 PDGFRB CLMN DNAH11	9.03e-05	197	102	5	608328608cef82adc867a449216839622253d486
ToppCell	Control-PLT_4\|Control / Disease Group and Platelet Clusters	CNNM2 PDCD4 ZNF451 VPS13B AGTPBP1	9.25e-05	198	102	5	387fd3037fd52e4d4c42de0588767e58af228b59
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	RALGAPA1 PNISR ZNF451 HERC1 VPS13B	9.47e-05	199	102	5	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SZT2 DOCK10 CLMN VAV3 FERMT3	9.47e-05	199	102	5	379bbd9cecf466b902411c54d74bd9885285b1ba
ToppCell	3'-Child04-06-SmallIntestine-Mesenchymal-Pericytes\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FILIP1 PDGFRB PGF CLMN DNAH11	9.47e-05	199	102	5	e751eb67510f8a5842dcfed44134160919cdb713
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	FILIP1 MYO5B ADGRV1 CNTN6 PATJ	9.69e-05	200	102	5	8683445ad5b70748c4a1f12eb77d47623085147e
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	RBM33 PNISR BIRC6 NUB1 NIPBL	9.69e-05	200	102	5	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	distal-Epithelial-Alveolar_Epithelial_Type_1\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	FILIP1 MYO5B CNTN6 EFR3B PATJ	9.69e-05	200	102	5	cbe3e107ac16c17687d73ebb04c39d51aba1fa98
ToppCell	Thalamus\|World / BrainAtlas - Mouse McCarroll V32	FREM3 CLMN VAV3 PATJ	1.47e-04	116	102	4	5ddfb2dd5459ff6d7ae38163a38eae64fda283b7
ToppCell	droplet-Fat-Mat-18m-Mesenchymal-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCDHB16 ANKRD24 FUT4 OPLAH	1.73e-04	121	102	4	e82c9e10b98c8d7ad828cf8ac19a2342014be2ba
Drug	Isoniazid [54-85-3]; Up 200; 29.2uM; HL60; HG-U133A	MYO1C GRK6 ITPRID2 PDCD4 PPM1B ARHGEF2 NIPBL NUP160 DDX28 AGTPBP1	1.90e-08	196	102	10	1399_UP
Drug	Atropine sulfate monohydrate [5908-99-6]; Down 200; 5.8uM; HL60; HG-U133A	GRK6 ITPRID2 ERBIN PDCD4 PPM1B ATG9A HERC1 NUP160 AGTPBP1	2.18e-07	193	102	9	1768_DN
Drug	2'-fucosyllactose	PYGB PYGL FUT4 CHPF	9.51e-06	30	102	4	CID000170484
Drug	5-(2-chloroethyl)uracil	PYGB PYGL	1.99e-05	2	102	2	CID010442204
Drug	6878P	PYGB PYGL	1.99e-05	2	102	2	CID002725013
Drug	AC1LBRFU	PYGB PYGL	1.99e-05	2	102	2	CID000562981
Drug	Hexetidine [141-94-6]; Down 200; 11.8uM; MCF7; HT_HG-U133A	RALGAPA1 GLRX3 PACS1 GREB1 ARHGEF2 FUT4 PATJ	2.55e-05	192	102	7	3318_DN
Drug	Praziquantel [55268-74-1]; Down 200; 12.8uM; MCF7; HT_HG-U133A	ITPRID2 PACS1 CLMN ZKSCAN3 DCAF17 ARHGEF2 PATJ	2.91e-05	196	102	7	7228_DN
Drug	Fluorometholone [426-13-1]; Down 200; 10.6uM; MCF7; HT_HG-U133A	U2AF2 TRIM52 STK10 ZKSCAN3 COPS7B VAV3 DDX28	2.91e-05	196	102	7	6247_DN
Drug	PHA-00816795 [212631-79-3]; Up 200; 10uM; PC3; HT_HG-U133A	MTHFSD SZT2 GLRX3 GRK6 DOCK10 PATJ NUP160	3.11e-05	198	102	7	7076_UP
Drug	Syrosingopine [84-36-6]; Down 200; 6uM; HL60; HG-U133A	MYO1C DOCK10 ITPRID2 PNISR PPM1B FUT4 MYL12B	3.11e-05	198	102	7	1761_DN
Drug	Lisuride (S)(-) [18016-80-3]; Up 200; 11.8uM; PC3; HG-U133A	GRK6 DOCK10 PPM1B STK10 COPS7B PYGB NIPBL	3.11e-05	198	102	7	1962_UP
Drug	Furosemide [54-31-9]; Down 200; 12uM; MCF7; HT_HG-U133A	RALGAPA1 GLRX3 RRAGB PACS1 CLMN ZKSCAN3 ARHGEF2	3.11e-05	198	102	7	6841_DN
Drug	Captopril [62571-86-2]; Down 200; 17.2uM; MCF7; HT_HG-U133A	TANC2 CNNM2 U2AF2 DIDO1 PACS1 TTC12 FUT4	3.21e-05	199	102	7	1488_DN
Drug	Sulconazole nitrate [61318-91-0]; Down 200; 8.6uM; PC3; HT_HG-U133A	RRAGB SRRT TTC12 DCAF17 ARHGEF2 PATJ NUP160	3.21e-05	199	102	7	6652_DN
Drug	3,5-dimethylphenyl isocyanate	PYGB PYGL	5.94e-05	3	102	2	CID000521488
Drug	5-ethyl-4-hydroxy-2-methyl-3(2H)-furanone	PYGB PYGL	5.94e-05	3	102	2	CID000093111
Drug	adenosine-5'-chloromethylphosphonate	PYGB PYGL	5.94e-05	3	102	2	CID000191554
Drug	hydan	PYGB PYGL	5.94e-05	3	102	2	CID000008360
Drug	EHMF	PYGB PYGL	5.94e-05	3	102	2	CID000033931
Drug	AC1L29EX	PYGB PYGL	5.94e-05	3	102	2	CID000043221
Drug	5'-deoxy-5'-fluoro-5'-(methylthio)adenosine	PYGB PYGL	5.94e-05	3	102	2	CID000147839
Drug	pyridoxal 5'-methylenephosphonate	PYGB PYGL	5.94e-05	3	102	2	CID003082249
Drug	Plp 5'-mpa	PYGB PYGL	5.94e-05	3	102	2	CID003082151
Drug	glucose-1,2-cyclic phosphate	PYGB PYGL	5.94e-05	3	102	2	CID000191723
Drug	3'-FFdUrd	PYGB PYGL	5.94e-05	3	102	2	CID000072260
Drug	2',3',4',5,5'-pentachloro-2-biphenylol	PYGB PYGL	5.94e-05	3	102	2	CID000119518
Drug	AC1L8XK3	PYGB PYGL	5.94e-05	3	102	2	CID000409735
Drug	N-acetyl-N'-beta-D-glucopyranosyl urea	PYGB PYGL	5.94e-05	3	102	2	CID000446801
Drug	NSC758405	PYGB PYGL	5.94e-05	3	102	2	CID000003201
Drug	3,5-dinitrophenyl phosphate	PYGB PYGL	5.94e-05	3	102	2	CID000151920
Drug	riboflavin tetraacetate	PYGB PYGL	5.94e-05	3	102	2	CID000094186
Drug	pyridoxal phosphoglucose	PYGB PYGL	5.94e-05	3	102	2	CID000196007
Drug	Aspaminol	PYGB PYGL	5.94e-05	3	102	2	CID003084278
Drug	2,5-dimethyl-3-furanone	PYGB PYGL	5.94e-05	3	102	2	CID000085730
Drug	3,5-dinitrophenol	PYGB PYGL	5.94e-05	3	102	2	CID000011459
Drug	sucrose-6-phosphate	PSMC4 PYGB PYGL	6.78e-05	18	102	3	CID000644101
Drug	diphenyl phosphonate	PGF PYGB PYGL	1.09e-04	21	102	3	CID006327546
Drug	galocitabine	PYGB PYGL	1.19e-04	4	102	2	CID000065950
Drug	2,5-anhydro-D-mannitol 1-phosphate	PYGB PYGL	1.19e-04	4	102	2	CID000189134
Drug	AC1LAMW2	PYGB PYGL	1.19e-04	4	102	2	CID000491364
Drug	FdUrd-C8	PYGB PYGL	1.19e-04	4	102	2	CID000094262
Drug	Mem-CC	PYGB PYGL	1.19e-04	4	102	2	CID003081269
Drug	5-deoxyribose-1-phosphate	PYGB PYGL	1.19e-04	4	102	2	CID000135786
Drug	2H-5a	PYGB PYGL	1.19e-04	4	102	2	CID000440102
Drug	ingliforib	PYGB PYGL	1.19e-04	4	102	2	CID006451325
Drug	uric acid riboside	PYGB PYGL	1.19e-04	4	102	2	CID000164933
Drug	pseudo-dl-glucose	PYGB PYGL	1.19e-04	4	102	2	CID000125259
Drug	BCIp4A	PYGB PYGL	1.19e-04	4	102	2	CID000192417
Drug	pyridoxal diphosphate	PYGB PYGL	1.19e-04	4	102	2	CID000125696
Drug	3'-chloromethotrexate	PYGB PYGL	1.19e-04	4	102	2	CID000097703
Drug	bromfenacoum	CNNM2 GLRX3 STXBP5L PSMC4 DIDO1 NDUFS1 NAPB CLMN ATG9A PATJ NUP160	1.47e-04	644	102	11	ctd:C013418
Drug	irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A	DIDO1 ERBIN VAV3 NIPBL VPS13B ATP6V0A2	1.77e-04	183	102	6	7498_DN
Drug	Harmine hydrochloride [343-27-1]; Down 200; 16uM; MCF7; HT_HG-U133A	PPM1B VAV3 ARHGEF2 NIPBL VPS13B ATP6V0A2	1.87e-04	185	102	6	7209_DN
Drug	heptulose-2-P	PYGB PYGL	1.97e-04	5	102	2	CID000124823
Drug	m-anisidine	PYGB PYGL	1.97e-04	5	102	2	CID000010824
Drug	6-FPLP	PYGB PYGL	1.97e-04	5	102	2	CID000146246
Drug	gluconohydroximo-1,5-lactone	PYGB PYGL	1.97e-04	5	102	2	CID009576855
Drug	2-hydroxypropylphosphonate	PYGB PYGL	1.97e-04	5	102	2	CID000441028
Drug	DHPBU	PYGB PYGL	1.97e-04	5	102	2	CID000125914
Drug	6-FDPL	PYGB PYGL	1.97e-04	5	102	2	CID000129578
Drug	5'-isobutylthioinosine	PYGB PYGL	1.97e-04	5	102	2	CID003080910
Drug	3'-O-methylpyridoxal 5'-phosphate	PYGB PYGL	1.97e-04	5	102	2	CID003082179
Drug	GlcMan	PYGB PYGL	1.97e-04	5	102	2	CID000152120
Drug	U66985	PYGB PYGL	1.97e-04	5	102	2	CID000127224
Drug	indirubin-5-sulphonate	PYGB PYGL	1.97e-04	5	102	2	CID005288641
Drug	VaraU	PYGB PYGL	1.97e-04	5	102	2	CID000126501
Drug	AC1O3M08	PYGB PYGL	1.97e-04	5	102	2	CID006331955
Drug	AC1LCUXJ	PYGB PYGL	1.97e-04	5	102	2	CID000656425
Drug	6-amino-5-bromouracil	PYGB PYGL	1.97e-04	5	102	2	CID000080578
Drug	etafenone	PYGB PYGL	1.97e-04	5	102	2	CID000003275
Drug	ddEtUrd	PYGB PYGL	1.97e-04	5	102	2	CID000451452
Drug	5-trifluoromethyl-2'-deoxycytidine	PYGB PYGL	1.97e-04	5	102	2	CID000125618
Drug	BrdAdo	PYGB PYGL	1.97e-04	5	102	2	CID000055914
Drug	Quercetine dihydrate [6151-25-3]; Down 200; 11.8uM; HL60; HT_HG-U133A	SZT2 DIDO1 SRRT FUT4 NUP160 ATP6V0A2	2.23e-04	191	102	6	2499_DN
Drug	Retinoic acid [302-79-4]; Down 200; 13.4uM; MCF7; HT_HG-U133A	GRK6 PNISR PDCD4 PYGB VAV3 GREB1	2.42e-04	194	102	6	6243_DN
Drug	Ethambutol dihydrochloride [1070-11-7]; Down 200; 14.4uM; HL60; HG-U133A	MYO1C U2AF2 PNISR PDCD4 PPM1B DDX28	2.49e-04	195	102	6	1981_DN
Drug	Oxymetazoline hydrochloride [2315-02-8]; Down 200; 13.4uM; MCF7; HT_HG-U133A	ERCC6 U2AF2 SRRT EDEM3 CLMN GREB1	2.49e-04	195	102	6	2278_DN
Drug	Acyclovir [59277-89-3]; Down 200; 17.8uM; HL60; HG-U133A	MYO1C GLRX3 DIDO1 PDCD4 ZKSCAN3 COPS7B	2.56e-04	196	102	6	2044_DN
Drug	Hydroflumethiazide [135-09-1]; Down 200; 12uM; PC3; HT_HG-U133A	DOCK10 PDCD4 TRIM52 SRRT PACS1 AGTPBP1	2.56e-04	196	102	6	7259_DN
Drug	Pentamidine isethionate [140-64-7]; Down 200; 6.8uM; HL60; HT_HG-U133A	CNNM2 SZT2 DIDO1 PYGB VAV3 NUP160	2.56e-04	196	102	6	2473_DN
Drug	Cefoperazone dihydrate; Down 200; 5.8uM; PC3; HT_HG-U133A	CNNM2 PACS1 TTC12 FUT4 NUP160 DDX28	2.56e-04	196	102	6	6323_DN
Drug	Pentoxifylline [6493-05-6]; Down 200; 14.4uM; HL60; HG-U133A	MYO1C GRK6 RSF1 PDCD4 PPM1B NIPBL	2.56e-04	196	102	6	1444_DN
Drug	alpha-estradiol; Down 200; 0.01uM; MCF7; HT_HG-U133A	PACS1 EDEM3 TTC12 PATJ NUP160 VPS13B	2.63e-04	197	102	6	6930_DN
Drug	Ganciclovir [82410-32-0]; Down 200; 15.6uM; PC3; HT_HG-U133A	TANC2 CNNM2 DIDO1 PACS1 ZKSCAN3 DCAF17	2.63e-04	197	102	6	6289_DN
Drug	Kanamycin A sulfate [25389-94-0]; Up 200; 6.8uM; HL60; HG-U133A	MTHFSD CNNM2 VAV3 ATG9A FUT4 CHPF	2.63e-04	197	102	6	1609_UP
Drug	2-propylpentanoic acid; Down 200; 200uM; MCF7; HT_HG-U133A	CNNM2 DIDO1 PACS1 CLMN TTC12 NIPBL	2.63e-04	197	102	6	6974_DN
Drug	16-phenyl tetranor Prostaglandin E2; Up 200; 10uM; MCF7; HT_HG-U133A	RALGAPA1 SZT2 GLRX3 DCAF17 FUT4 PATJ	2.63e-04	197	102	6	7505_UP
Drug	Nimesulide [51803-78-2]; Down 200; 13uM; HL60; HG-U133A	CNNM2 MYO1C SZT2 GRK6 DIDO1 PDCD4	2.70e-04	198	102	6	1428_DN
Drug	Atropine-N-oxide hydrochloride [4574-60-1]; Up 200; 11.8uM; PC3; HT_HG-U133A	GLRX3 STXBP5L DOCK10 PGF GREB1L SRRT	2.70e-04	198	102	6	4476_UP
Drug	Doxycycline hydrochloride [10592-13-9]; Up 200; 8.4uM; MCF7; HT_HG-U133A	DIDO1 RRAGB PDCD4 GREB1 FUT4 PATJ	2.70e-04	198	102	6	3479_UP
Drug	Amidopyrine [58-15-1]; Up 200; 17.2uM; HL60; HG-U133A	CNNM2 GRK6 PDCD4 ZKSCAN3 NIPBL DDX28	2.70e-04	198	102	6	1376_UP
Drug	Chenodiol [474-25-9]; Down 200; 10.2uM; MCF7; HT_HG-U133A	GLRX3 GRK6 DIDO1 PNISR SRRT GREB1	2.78e-04	199	102	6	7433_DN
Drug	Dextromethorphan hydrobromide monohydrate [6700-34-1]; Down 200; 10.8uM; PC3; HT_HG-U133A	MYO1C GRK6 PNISR PACS1 TTC12 COPS7B	2.78e-04	199	102	6	6300_DN
Drug	(-)-Eseroline fumarate salt [104015-29-4]; Down 200; 12uM; PC3; HT_HG-U133A	GRK6 DIDO1 PACS1 COPS7B VPS13B DDX28	2.78e-04	199	102	6	7267_DN
Drug	Bromperidol [10457-90-6]; Down 200; 9.6uM; MCF7; HT_HG-U133A	GRK6 PNISR FUT4 NIPBL VPS13B AGTPBP1	2.78e-04	199	102	6	2872_DN
Drug	Hydrocortisone base [50-23-7]; Down 200; 11uM; MCF7; HT_HG-U133A	TANC2 SPATA7 PYGB ARHGEF2 CHPF NIPBL	2.85e-04	200	102	6	5284_DN
Drug	norstatine	PYGB PYGL	2.95e-04	6	102	2	CID000173844
Drug	CV-araU	PYGB PYGL	2.95e-04	6	102	2	CID006441877
Drug	2-thiothymidine	PYGB PYGL	2.95e-04	6	102	2	CID003005944
Disease	childhood trauma measurement, alcohol consumption measurement	TANC2 INTU PCDHGA7 PCDHGA2	9.37e-05	71	98	4	EFO_0007878, EFO_0007979
Disease	smoking cessation	CNNM2 RBM33 DGKZ BIRC6 TTC12 FERMT3	7.67e-04	325	98	6	EFO_0004319
Disease	1-stearoyl-2-linoleoyl-GPI (18:0/18:2) measurement	MYO5B DOCK7	8.32e-04	13	98	2	EFO_0800413
Disease	Connective Tissue Diseases	PRDM5 PIEZO2	8.32e-04	13	98	2	C0009782
Disease	body fat percentage	RALGAPA1 HYOU1 PACS1 EDEM3 TTC12 PATJ UNC79	1.23e-03	488	98	7	EFO_0007800
Disease	aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement	HYOU1 PACS1 EDEM3 TTC12 PATJ UNC79	1.37e-03	364	98	6	EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946
Disease	mean arterial pressure	CNNM2 SZT2 DOCK10 DGKZ EDEM3 METTL21A EFR3B	1.40e-03	499	98	7	EFO_0006340
Disease	Infiltrating duct carcinoma of female breast	PDGFRB GRK6	2.20e-03	21	98	2	C3165106
Disease	Sarcosine measurement	PCDHGA7 PCDHGA2	2.64e-03	23	98	2	EFO_0021668
Disease	glioblastoma (is_implicated_in)	PDGFRB PGF	2.87e-03	24	98	2	DOID:3068 (is_implicated_in)
Disease	Dystonia	ERCC6 PDGFRB DCAF17	2.98e-03	86	98	3	C0013421
Disease	mental development measurement	PCDHGA7 PCDHGA2	3.12e-03	25	98	2	EFO_0008230

Protein segments in the cluster

Peptide	Gene	Start	Entry
PEYDLNVEERLVLIE	ERBIN	731	Q96RT1
DEDFIKIIVLEIYEV	EPG5	791	Q9HCE0
IVDYEDELDLLSVVA	DCAF17	426	Q5H9S7
ELLVEYDLPALLDQE	BIRC6	3506	Q9NR09
RELEDLIIEAVYTDI	COPS7B	126	Q9H9Q2
REDFPLIETEDEAYL	ARHGEF2	576	Q92974
VVDDDLPEEAEAYLL	ADGRV1	471	Q8WXG9
ITILEDDVPELEEYF	ADGRV1	2906	Q8WXG9
TLLEVEYPLIEDELR	DNAH11	776	Q96DT5
EYPLIEDELRAIDEQ	DNAH11	781	Q96DT5
ELSELREFYDPDTVE	DPY19L3	546	Q6ZPD9
EVEALAEVIPLALYD	ANKRD24	476	Q8TF21
TYVLDEDEPRFLEEV	AGTPBP1	1171	Q9UPW5
RYLVEVEELAEEVLA	PDRG1	11	Q9NUG6
LYTDEVLDIEINEPL	RBM33	171	Q96EV2
YPELVLERVLDREEE	PCDHGA7	191	Q9Y5G6
YPELVLERSLDREEE	PCDHGA2	191	Q9Y5H1
YERDTLLVEPEEVVE	RAD17	426	O75943
ELDAQEYELLVLPEA	LARGE2	646	Q8N3Y3
EDIETDTELLIGYLD	PRDM5	111	Q9NQX1
YLDSTLEDEEIIIAE	NUB1	586	Q9Y5A7
TEILELFLDDEVIEL	ERCC6	611	P0DP91
YHPRLIIYEEEEEEE	PAXIP1	181	Q6ZW49
LVRLTEVDVYDEEEI	GREB1	1366	Q4ZG55
VEYETFDILEDEEVR	GLRX3	276	O76003
EEVDLRVLDYEEAAA	FUT4	261	P22083
EDLDEQIYIITLEEE	LMBR1	231	Q8WVP7
EGSIILDAIREYEEV	EDEM3	771	Q9BZQ6
LDAIREYEEVEVLLS	EDEM3	776	Q9BZQ6
VPLTLEDLEEVDLLY	HERC1	4611	Q15751
VYETVVLPLDERAFE	PDCD4	151	Q53EL6
EKEERVPAEEITYET	EFR3B	711	Q9Y2G0
YDEVELDALAEIERI	NIPBL	466	Q6KC79
LLDESFLELVDYILE	DDX28	291	Q9NUL7
YPELVLDTELDREEQ	PCDHB15	191	Q9Y5E8
LIRLLEVDVYDEEEI	GREB1L	1341	Q9C091
ELLELYEEDPEEILY	ITPRID2	171	P28290
REQIREVEEDLDELY	PACS1	356	Q6VY07
FYLELSEDEEESLLP	INTU	66	Q9ULD6
EFDLILGADIIYLEE	METTL21A	136	Q8WXB1
YPELVLDKELDREEE	PCDHB16	191	Q9NRJ7
VVYPILVEFTREVEE	HYOU1	441	Q9Y4L1
RLLEPLDYETVIEEL	DOCK10	46	Q96BY6
LTEAVDPVDLEDYLI	DOCK7	51	Q96N67
EVVEYVDDLLELEET	CRTAP	386	O75718
LIALTIYDEDVLAVE	ATG9A	391	Q7Z3C6
LTYEEIERLLEEEAV	AXDND1	821	Q5T1B0
EDYELPEEILEKIRS	DLGAP3	821	O95886
REEVAYDPEDETILE	DIDO1	1421	Q9BTC0
ELLVPFEEDYLIEIR	CNTN6	961	Q9UQ52
LEEVELLYEFLLAEL	FAM180A	51	Q6UWF9
LEEVLTAEYLLEEFR	IDE	446	P14735
TAEYLLEEFRPDLIE	IDE	451	P14735
EIAQDEIYILDPELL	DGKZ	741	Q13574
EVERLVKEVPEEYSE	GRK6	396	P43250
EEDELLRVTDLVDYV	RSF1	1421	Q96T23
DAEELFIFLTEITEI	PDGFRB	131	P09619
IDVQEPELEDLARYD	RGPD1	401	P0DJD0
DEEVDELYREAPIDK	MYL12B	136	O14950
YEEIALDLTPVIEEL	FAN1	436	Q9Y2M0
VLIIDDSLYEEEESF	FREM3	1966	P0C091
VLITEDDEYVRLFLE	PLD6	186	Q8N2A8
VVTESDPELEVEYRE	SZT2	1501	Q5T011
EEVDLEDYVARPDKI	PSMC4	356	P43686
YRETDIDEVLAEREE	PSD	296	A5PKW4
EDVYEKPISELDRLE	FILIP1	141	Q7Z7B0
LEEVSPNLVRYDDIE	NDUFS1	646	P28331
PEVLYEEVLEVDERV	OPLAH	126	O14841
IVSYLLDLPEKDEEE	TANC2	1006	Q9HCD6
VYEILRAEEDEFIIL	PPM1B	226	O75688
LLEEAVDLVSEYVDA	NUP160	1346	Q12769
EVRLQYDVEDIITPE	STXBP5L	556	Q9Y2K9
ITDYLIEEVSAEEEE	SRRT	561	Q9BXP5
DLSVEEDEEVLTLLY	CFAP20DC	656	Q6ZVT6
LAAVLEAYVEDPEDL	CLMN	736	Q96JQ2
EQEEELLESLDVYEL	CHPF	696	Q8IZ52
LRDVVAIDLIDDYPE	C12orf56	76	Q8IXR9
YEVLGIVTLEDVIEE	CNNM2	561	Q9H8M5
PDLRIDVYREEEILE	TRIM52	141	Q96A61
PVLEYIDLVSSDDEE	ZNF451	41	Q9Y4E5
DEEDVLDELLQYLGV	RALGAPA1	1676	Q6GYQ0
ERLVDVVSEYPSEVE	PGF	56	P49763
EEREILVDEEYELYQ	PATJ	866	Q8NI35
EVLIYVFDVESRELE	RRAGA	86	Q7L523
VIETKSEEELEDYIV	STK10	66	O94804
SEEELEDYIVEIEIL	STK10	71	O94804
EELVEEHDITVDYIL	MTHFSD	191	Q2M296
LVRETGELELEEDLY	PIEZO2	2716	Q9H5I5
EAIYQLGLDLEELEE	PYGB	111	P11216
DEEELLYLSFIEDVT	SPATA7	361	Q9P0W8
VEVLIYVFDVESREL	RRAGB	146	Q5VZM2
EPEEELYDLSKVVLA	FERMT3	156	Q86UX7
TIAEIYETELVDIEK	NAPB	126	Q9H115
PEELLDDEEYEEIVE	U2AF2	386	P26368
ETILNPEEVALLEEY	VPS13B	621	Q7Z7G8
EVVVLLEYLERQLDE	ZKSCAN3	116	Q9BRR0
EEDVDLFREVIYTLL	TTC12	486	Q9H892
LLTEILLDVTDEEIY	PNISR	341	Q8TF01
TEFLEEVIEALILDE	UBE4A	246	Q14139
EAIYQLGLDIEELEE	PYGL	111	P06737
DEIILPRGLEYTVEE	TNFRSF17	111	Q02223
PYDIAVVSLEEDLDD	TYSND1	406	Q2T9J0
IVSYAELDESLEDPE	ATP6V0A2	201	Q9Y487
EEYDEETLGLAIVVL	UNC79	2016	Q9P2D8
DLIDETLVEDEEDLY	VAV3	146	Q9UKW4
LTVIDFTEDEVEDLL	MYO1C	291	O00159
RLEDETILEYPIDVQ	MYO5B	41	Q9ULV0